株式会社グローバルインフォメーション
TEL: 044-952-0102
市場調査レポート

欧州諸国(フランス・ドイツ・イタリア・スペイン・英国)の核酸検査市場

Europe Nucleic Acid Testing Market: Future Horizons and Growth Strategies--Instrument and Reagents Supplier Shares, Country Segment Forecasts, Competitive Intelligence, Opportunities

発行 Venture Planning Group 商品コード 238432
出版日 ページ情報 英文 1273 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=115.27円で換算しております。

Local License: 同一事業所内

Back to Top
欧州諸国(フランス・ドイツ・イタリア・スペイン・英国)の核酸検査市場 Europe Nucleic Acid Testing Market: Future Horizons and Growth Strategies--Instrument and Reagents Supplier Shares, Country Segment Forecasts, Competitive Intelligence, Opportunities
出版日: ページ情報: 英文 1273 Pages
概要

当レポートでは、欧州の主要5カ国(フランス・ドイツ・イタリア・スペイン・英国)における核酸診断市場の最新動向と将来展望について分析し、検査技術の研究開発の最新動向、各国市場の基本構造・動向、今後5年間の市場動向予測、市場拡大のための戦略と課題、主要企業プロファイルといった情報を盛り込んで、概略以下の構成でお届けします。

イントロダクション

世界市場と技術概要

  • DNAシーケンシング
    • イントロダクション
    • シーケンシング手法
    • オートラジオグラフィー
    • ヒトゲノムプロジェクト
    • シーケンシングの自動化
    • イメージスキャナ
    • 蛍光検出
    • 遺伝子プロファイリング
    • 遺伝子発現
    • 遺伝子多型
    • タンパク質間相互作用ネットワークk
  • DNAおよびRNAプローブ技術
    • 基本的原則
    • プローブの分離
    • DNAプローブ検査
    • 検査フォーマット
    • 標識技術
    • 増幅手法
  • 検出技術
    • 放射線による手法
    • 非アイソトープ式手法
  • 装置レビュー
    • Abbott LCx
    • Beckman Coulter/Biomek FK
    • Becton Dickinson SDA
    • Bio-Rad GeneScope
    • Gen-Probe Tigris
    • Roche Cobas Amplicor
    • Tecan LS Series
  • バイオチップ:ゲノセンサー、マイクロアレイ、ラボオンチップ
  • ファーマコゲノミクス
  • 主な応用分野
    • 微生物/感染症
    • がん検査
    • 遺伝子疾患
    • 法医学検査
    • 実父確定検査/HLA型決定
    • その他の応用分野
  • 競合/補完技術
    • モノクローナル抗体/免疫検定
    • RNAプローブ
    • 二次元電気泳動
    • フローサイトメトリー

フランス市場

  • エグゼクティブ・サマリー
  • 事業環境
  • 市場構造
  • 市場規模・成長率、主要サプライヤーの売上高・市場シェア

ドイツ市場

  • エグゼクティブ・サマリー
  • 事業環境
  • 市場構造
  • 市場規模・成長率、主要サプライヤーの売上高・市場シェア

イタリア市場

  • エグゼクティブ・サマリー
  • 事業環境
  • 市場構造
  • 市場規模・成長率、主要サプライヤーの売上高・市場シェア

スペイン市場

  • エグゼクティブ・サマリー
  • 事業環境
  • 市場構造
  • 市場規模・成長率、主要サプライヤーの売上高・市場シェア

英国市場

  • エグゼクティブ・サマリー
  • 事業環境
  • 市場構造
  • 市場規模・成長率、主要サプライヤーの売上高・市場シェア

主な製品開発機会

  • 機器
  • 試薬キットおよび検査システム/パネル
  • コンピューター・ソフトウェア・オートメーション
  • 補助製品

分散型検査製品の設計基準

代替的な市場浸透戦略

  • 内部開発
  • 共同事業協定
  • 大学との契約
  • 分散型検査市場の流通戦略
    • マーケティングのアプローチ
    • 製品の複雑性
    • 顧客の選好
    • 既存のサプライヤー
    • 新規参入サプライヤー
    • 主な種類の流通業者
    • 市場の分類

潜在的な市場参入障壁とリスク

  • 市場の成熟化
  • コスト抑制
  • 競争
  • 技術の限界
  • 特許保護
  • 規制による抑制
  • 分散型検査市場の課題

競合企業プロファイル

  • Abbott
  • Affymetrix
  • Agilent
  • Applied Gene Technologies
  • Arca
  • Beckman Coulter/Danaher
  • Becton Dickinson
  • Biokit
  • BioMerieux
  • Bio-Rad
  • Biotest
  • Caliper
  • Cepheid
  • Decode
  • Diadexus
  • 栄研化学
  • Enzo
  • Exact Sciences
  • 富士レビオ
  • Gen-Probe
  • Hologic
  • Illumina
  • Innogenetics/Solvay
  • Kreatech
  • Li-Cor Biosciences
  • Life Technologies
  • Monogram Biosciences
  • Myriad Genetics
  • Nanogen/Elitech
  • Novartis
  • Orchid CellMark
  • Ortho-Clinical Diagnostics
  • Proteome Sciences
  • Qiagen
  • Roche
  • Scienion
  • Sequenom
  • 島津製作所
  • Siemens
  • Sierra Molecular
  • タカラバイオ
  • Tecan Group

付録

  • 付録I:主な大学・研究機関
  • 付録II:用語集
  • 付録III:為替レート

図表一覧

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: VPNAT20516

This comprehensive five-country report is designed to help current suppliers and potential market entrants identify and evaluate major business opportunities emerging in the molecular diagnostics market during the next five years. The report explores business and technological trends in major European countries (France, Germany, Italy, Spain, UK); provides 5-year test volume/sales forecasts; estimates shares of leading competitors; compares features of major analyzers; profiles leading market players; and identifies specific product and business opportunities facing instrument and consumable suppliers during the next five years.

The $4.5 billion molecular diagnostics market is unquestionably the most rapidly growing segment of the in vitro diagnostics industry. The next five years will witness significant developments in reagent systems and automation, as well as introduction of a wide range of new products that will require innovative marketing approaches. The rate of market penetration into routine clinical laboratories, however, will depend on the introduction of cost-effective and automated systems with amplification methods.

In order to successfully capitalize on the opportunities presented by the molecular diagnostics market, many companies are already exploiting new technologies as corporate strategic assets, managed in support of business and marketing strategies. Integrating new technology planning with business and corporate strategies will be one of the most challenging tasks for diagnostics companies during the next five years.  

Contains 1,273 pages and 139 tables         

Table of Contents

Introduction

Worldwide Market And Technology Overview

  • A. DNA Sequencing
    • 1. Introduction
    • 2. Sequencing Methods
    • 3. Autoradiography
    • 4. The Human Genome Project
    • 5. Sequencing Automation
    • 6. Image Scanners
    • 7. Fluorescent Detection
    • 8. Gene Profiling
    • 9. Gene Expression
    • 10. Polymorphism Screening
    • 11. Protein Interaction Networks
  • B. DNA And RNA Probe Technology
    • 1. Basic Principles
    • 2. Probe Preparation
    • 3. The DNA Probe Test
      • a. Sample Preparation
      • b. Hybridization
      • c. Separation
      • d. Detection/Measurement
    • 4. Test Formats
      • a. Filter Hybridization
      • b. Southern Blot
      • c. Northern Blot
      • d. In Situ Hybridization
      • e. Others
    • 5. Labeling Techniques
    • 6. Amplification Methods
      • Polymerase Chain Reaction
        • Temperature Cyclers
        • PCR Variations
          • Immuno-PCR
          • QC-PCR
          • DAP-PCR
      • Strand Displacement Activation
      • TMA
      • Ligase Chain Reaction
      • Branched DNA
        • Hybridization Protection Assay
      • Nucleic-Acid Sequence-Based Amplification
      • Self-Sustained Sequence Replicase
      • Others
        • Ampliprobe
        • CAR
        • CAS
        • CPT
        • Dendritic Polymer Technology
        • ISO-CR
        • LAT
        • Probe Networks
        • RAMP
        • Repair Chain Reaction
        • Rolling Circles
        • Sequence Independent Gene Amplification
        • Sequence Initiation Reaction
        • SISPA
        • Solid Phase Amplification
  • C. Detection Technologies
    • 1. Radioactive Methods
      • a. Overview
      • b. Major Isotopes
        • P-32
        • S-35
        • H-3
        • I-125
    • 2. Non-Isotopic Methods
      • a. Enzymatic Labels
      • b. Chemical Labeling
        • Indirect Chemical Labeling
        • Direct Chemical Labeling
      • c. Fluorescence
      • d. Chemiluminescence
      • e. Electrical Conductivity
  • D. Instrumentation Review
    • 1. Abbott LCx
    • 2. Beckman Coulter/Biomek FK
    • 3. Becton Dickinson SDA
    • 4. Bio-Rad GeneScope
    • 5. Gen-Probe Tigris
    • 6. Roche Cobas Amplicor
    • 7. Tecan LS Series
  • E. Biochips: Genosensors, Microarrays, and Labs-on-the-Chip
    • Liquid Transportation and Mixing
    • Separation
    • Reaction
    • Detection
  • F. Pharmacogenomics
  • G. Major Applications
    • 1. Microbiology/Infectious Diseases
      • a. Overview
      • b. Major Infectious Diseases
        • AIDS
          • Structure and Composition
          • Classification
          • AIDS Origins
          • Animal Lentivirus Systems
          • Virus Receptors
          • HIV Infections in Humans
            • Pathogenesis and Pathology
          • CD4T Lymphocytes and Memory Cells
          • Monocytes and Macrophages
          • Lymphoid Organs
          • Neural Cells
          • Viral Coinfections
            • Clinical Findings
          • Plasma Viral Load
          • Pediatric AIDS
            • Neurologic Disease
            • Opportunistic Infections
            • Cancer
          • Immunity
            • Virus Isolation
            • Serology
            • Viral Nucleic Acid/Antigen Detection
          • Epidemiology
            • Worldwide Spread of AIDS
            • United States
            • Routes of Transmission
          • DNA Probes
            • Overview
            • Quantitative PCR
            • In Situ PCR
            • Needed Improvements
          • Viral Load/Drug Resistance Testing
          • Genotype and Phenotype Testing
          • Blood Banking Considerations
            • Adenovirus
          • Background
          • Diagnostic Tests
          • Vaccines and Drugs
          • Adeno-Associated Viruses (AAV)
        • Anthrax/Bacillus Anthracis
          • Background
          • Diagnostic Tests
          • Vaccines and Drugs
        • Babesiosis
          • Background
        • BEA and Other Bartonella Diseases
          • Background
          • Diagnostic Tests
          • Vaccines and Drugs
        • Chagas Disease
          • Background
        • Campylobacter
          • Background
            • Diagnostic Tests
              • Culture Identification
            • Vaccines and Drugs
        • Chlamydia
          • Background
            • Chlamydia psittaci
            • Chlmaydia pneumoniae
            • Chlamydia trachomatis
          • Diagnostic Tests
          • Vaccines and Drugs
        • Creutzfeldt-Jakob's Disease
          • Background
          • Blood Transmission
          • Diagnostic Tests
          • Major Commercial and Academic Players
            • Bayer
            • Disease Sciences/Bio Tec Global
            • Imperial College School of Medicine
            • Ortho-Clinical Diagnostics
            • Pall
            • ProMetic Life Sciences
            • Proteome Sciences/Idexx
            • Q-One Biotech
            • Serono
            • U.S. Agricultural Research Service
        • Drugs
        • Vaccines
          • Cytomegalovirus
            • Background
              • Chorioretinitis
              • Gastrointestinal
              • Central Nervous System Disease
                • Diagnostic Tests
                • Vaccines and Drugs
          • Ebola Virus
            • Background
              • Epidemiology
            • Clinical Syndromes
          • Diagnostic Tests
          • Vaccines and Drugs
          • EchoVirus
            • Background
              • Acute Aseptic Meningitisis
              • Encephalitis
              • Exanthems
              • Respiratory Disease
              • Myopericarditis
              • Neonatal Infections
                • Diagnostic Tests
                • Vaccines and Drugs
          • Encephalitis
            • Background
            • Diagnostic Tests
            • Vaccines and Drugs
          • Enteroviruses
            • Background
            • Diagnostic Tests
              • Viral Isolation and Identification
              • Antibody Tests
            • Vaccines and Drugs
          • Epstein-Barr Virus
            • Background
            • Diagnostic Tests
            • Vaccines and Drugs
          • Gonorrhea
            • Background
            • Diagnostic Tests
            • Vaccines and Drugs
              • Hepatitis
          • Hepatitis A
          • Hepatitis B
            • Structure and Composition
            • Replication
          • Hepatitis C
          • Hepatitis D (Delta)
          • Hepatitis E
          • Hepatitis G
          • Hepatitis Infections Pathology
          • Clinical Findings
          • Laboratory Tests
        • Hepatitis A
        • Hepatitis B
        • Hepatitis C
        • Hepatitis D
        • Hepatitis E
          • Virus-Host Immune Reactions
          • Epidemiology
        • Hepatitis A
        • Hepatitis B
        • Hepatitis C
        • Hepatitis D (Delta)
          • Vaccines and Drugs
        • Herpes Simplex Virus
          • Background
          • Diagnostic Tests
          • Vaccines and Drugs
        • Legionella
          • Background
          • Diagnostic Tests
          • Vaccines and Drugs
        • Lyme Disease
          • Background
            • Clinical Description
            • Clinical Case Definition
            • Laboratory Criteria for Diagnosis
            • Case Classification
          • Diagnostic Tests
          • Vaccines and Drugs
            • Malaria
        • Mycoplasma
          • Background
            • Ureaplasma Urealyticum & Mycoplasma
            • Hominis
          • Diagnostic Tests
          • Vaccines and Drugs
        • Papillomaviruses/HPV
          • Background
            • HPV in Cancer
            • Cervical Neoplasm
          • Diagnostic Tests
          • Vaccines and Drugs
            • Prevention
        • Parvovirus B19
          • Background
            • Microbiology
            • Epidemiology
            • Clinical Syndromes
            • Erythema Infectiosum (Slapped Cheek)
            • Adult Polyarthropathy
            • Transient Aplastic Crisis
            • Transient Pancytopenia
            • Red Cell Aplasia in Immunocompromised
            • Perinatal Infections
          • Diagnostic Test
          • Vaccines and Drugs
        • Pneumonia
          • Background
          • Diagnostic Tests
          • Vaccines and Drugs
        • Polyomaviruses
          • Background
          • Diagnostic Tests
          • Vaccines and Drugs
        • Salmonellosis
          • Background
          • Diagnostic Tests
          • Vaccines and Drugs
        • Shigellosis
          • Background
          • Diagnostic Tests
          • Vaccines and Drugs
        • Streptococci
          • Background
          • Diagnostic Tests
          • Vaccines and Drugs
            • Group A Streptococci
            • Group B Streptococci
        • Toxoplasmosis
          • Background
          • Diagnostic Tests
          • Vaccines and Drugs
        • Tuberculosis
          • Background
          • Diagnostic Tests
            • Microscopic Characteristics
            • Cultural Characteristics
            • Skin Tests
            • MDRTB
          • Vaccines and Drugs
        • West Nile Virus
          • Background
            • Clinical Syndromes
          • Diagnostic Tests
          • Vaccines and Drugs
        • Yersinia
          • Background
          • Diagnostic Tests
          • Vaccines and Drugs
      • c. Antibiotic Susceptibility
    • 2. Cancer Testing
      • a. Overview
      • b. Major Cancer Types
        • Prostate
        • Lung
        • Colon and Rectum
        • Breast
        • Skin
        • Uterine
        • Leukemia
        • Oral
      • c. Oncogenes
        • Abl/abl-bcr
        • AIB1
        • BCL-2
        • BRCA1
        • CD44
        • C-fos
        • C-myb
        • C-myc
        • CYP17
        • Erb-B
        • HPC1
        • N-myc
        • P40
        • P51
        • P53
        • PIK3CA
        • PTI-1
        • Ras
        • Reg
        • Sis
        • Src
    • 3. Genetic Diseases
      • a. Overview
      • b. Nucleic Acid Amplification
      • c. Chromosome Imaging
      • d. Genomics Technologies
      • e. Proteomics Technologies
      • f. Current Pharmacogenomic Tests
      • g. Future Pharmacogenomic Testing
      • h. Major Diseases
        • Achondroplasia
        • Autosomal Dominant Polycystic Kidney Disease
          • Cancer
          • Cosmetogenomics
          • Cystic Fibrosis
          • Down's Syndrome
          • Duchenne and Becker Muscular Dystrophy
          • Factor V (Leiden)
          • Factor IX Deficiency
          • Fragile X Syndrome
          • Heart Disease
          • Hemochomatosis
          • Hemophilia
          • Huntington's Disease
          • Maternal-Fetal Incompatibility
          • Multiple Endocrine Neoplasia
          • Phenylketonuria (PKU)
          • Polycystic Kidney Disease (PKD)
          • Prenatal Screening
          • Retinitis Pigmentosa
          • Retinoblastoma
          • Sickle Cell Anemia
          • Spinal Muscular Atrophy
          • Vitamin B12 Metabolism
      • i. Social Issues and Concerns
    • 4. Forensic Testing
      • a. Overview
      • b. Multilocus and Single Locus Probes
        • Multilocus Probes
        • Single Locus Probes
        • PCR and RFLP
      • c. The FBI
      • d. DNA Profile Data Banks
        • U.S.A.
        • U.K.
      • e. Judicial Implementation
      • f. Major Crime Categories
      • g. Factors Contributing to the DNA Probe Market Expansion
        • Technology Availability
        • Use of Hair as Evidence
      • h. Wildlife Forensics
    • 5. Paternity Testing/HLA Typing
    • 6. Other Applications
      • a. Disease Susceptibility Testing
      • b. Cardiovascular Diseases
      • c. Diabetes
      • d. Alzheimer's Disease
      • e. Periodontal Disease
      • f. Plasma Purification
      • g. Organ Transplantation
      • h. Water Contamination
      • i. Other
  • H. Competing/complementing Technologies
    • 1. Monoclonal Antibodies/Immunoassays
    • 2. RNA Probes
    • 3. Two-Dimensional Electrophoresis
    • 4. Flow Cytometry

France

  • A. Executive Summary
  • B. Business Environment
  • C. Market Structure
  • D. Market Size, Growth And Major Suppliers' Sales And Market Shares

Germany

  • A. Executive Summary
  • B. Business Environment
  • C. Market Structure
  • D. Market Size, Growth And Major Suppliers' Sales And Market Shares

Italy

  • A. Executive Summary
  • B. Business Environment
  • C. Market Structure
  • D. Market Size, Growth And Major Suppliers' Sales And Market Shares

Spain

  • A. Executive Summary
  • B. Business Environment
  • C. Market Structure
  • D. Market Size, Growth And Major Suppliers' Sales And Market Shares

U.K.

  • A. Executive Summary
  • B. Business Environment
  • C. Market Structure
  • D. Market Size, Growth And Major Suppliers' Sales And Market Shares

Major Product Development Opportunities

  • A. Instrumentation
  • B. Reagent Kits and Test Systems/panels
  • C. Computers, Software and Automation
  • D. Auxiliary Products

Design Criteria For Decentralized Testing Products

Alternative Market Penetration Strategies

  • A. Internal Development
  • B. Collaborative Arrangements
  • C. University Contracts
  • D. Distribution Strategies For Decentralized Testing Markets
    • 1. Marketing Approaches
    • 2. Product Complexity
    • 3. Customer Preference
    • 4. Established Suppliers
    • 5. Emerging Suppliers
    • 6. Major Types Of Distributors
    • 7. Market Segmentation

Potential Market Entry Barriers And Risks

  • A. Market Maturity
  • B. Cost Containment
  • C. Competition
  • D. Technological Edge And Limitations
  • E. Patent Protection
  • F. Regulatory Constraints
  • G. Decentralized Testing Market Challenges

Competitive Profiles

  • Abbott
  • Affymetrix
  • Agilent
  • Applied Gene Technologies
  • Arca
  • Beckman Coulter/Danaher
  • Becton Dickinson
  • Biokit
  • BioMerieux
  • Bio-Rad
  • Biotest
  • Caliper
  • Cepheid
  • Decode
  • Diadexus
  • Eiken
  • Enzo
  • Exact Sciences
  • Fujirebio
  • Gen-Probe
  • Hologic
  • Illumina
  • Innogenetics/Solvay
  • Kreatech
  • Li-Cor Biosciences
  • Life Technologies
  • Monogram Biosciences
  • Myriad Genetics
  • Nanogen/Elitech
  • Novartis
  • Orchid CellMark
  • Ortho-Clinical Diagnostics
  • Proteome Sciences
  • Qiagen
  • Roche
  • Scienion
  • Sequenom
  • Shimadzu
  • Siemens
  • Sierra Molecular
  • Takara Bio
  • Tecan Group

Appendixes

  • Appendix I: Major Universities and Research Centers Developing Molecular Diagnostic Technology
  • Appendix II: Glossary of Terms
  • Appendix III: Currency Exchange Rates

List of Tables

  • Major Companies Developing or Marketing AIDS Molecular Diagnostic And Other Direct Identification Tests
  • Major Companies Developing or Marketing Adenovirus Molecular Diagnostic And Other Direct Identification Tests
  • Major Companies Developing or Marketing Campylobacter Molecular Diagnostic And Other Direct Identification Tests
  • Major Companies Developing or Marketing Chlamydia Molecular Diagnostic And Other Direct Identification Tests
  • Major Companies Developing or Marketing CMV Molecular Diagnostic And Other Direct Identification Tests
  • Major Companies Developing or Marketing EBV Molecular Diagnostic And Other Direct Identification Tests
  • Major Companies Developing or Marketing Gonorrhea Molecular Diagnostic And Other Direct Identification Tests
  • Major Companies Developing or Marketing Hepatitis Molecular Diagnostic And Other Direct Identification Tests
  • Major Companies Developing or Marketing Herpes Molecular Diagnostic And Other Direct Identification Tests
  • Major Companies Developing or Marketing Legionella Molecular Diagnostic And Other Direct Identification Tests
  • Major Companies Developing or Marketing Lyme Disease Molecular Diagnostic And Other Direct Identification Tests
  • Major Companies Developing or Marketing Mycoplasma Molecular Diagnostic And Other Direct Identification Tests
  • Major Companies Developing or Marketing Papilloma Virus Molecular Diagnostic And Other Direct Identification Tests
  • Major Companies Developing or Marketing Pneumonia Molecular Diagnostic And Other Direct Identification Tests
  • Major Companies Developing or Marketing Salmonella Molecular Diagnostic And Other Direct Identification Tests
  • Major Companies Developing or Marketing Shigella Molecular Diagnostic And Other Direct Identification Tests
  • Major Companies Developing or Marketing Streptococci Molecular Diagnostic And Other Direct Identification Tests
  • Major Companies Developing or Marketing Toxoplasmosis Molecular Diagnostic And Other Direct Identification Tests
  • Major Companies Developing or Marketing Tuberculosis Molecular Diagnostic And Other Direct Identification Tests
  • Oncogenes Potential Application in Cancer Diagnosis
  • Major Companies Developing or Marketing Cancer Molecular Diagnostic Tests
  • Major Companies Developing or Marketing Molecular Diagnostic Test For Genetic Diseases
  • Summary Table France, Molecular Diagnostic Test Volume And Sales Forecast by Major Application
  • France, Laboratories Performing DNA Sequencing By Market Segment
  • France, Molecular Diagnostics Market Potential Laboratory Universe by Market Segment
  • France, Molecular Diagnostic Test Volume Forecast By Major Application
  • France, Major Infectious Disease Molecular Diagnostics Test Volume Forecast
  • France, Infectious Disease Screening NAT Volume Forecast
  • France, Molecular Diagnostics Market Forecast By Major Application
  • France, Infectious Disease Screening NAT Reagent Market Forecast by Test
  • France, Molecular Diagnostics Market By Major Supplier
  • France, HIV/Hepatitis NAT Market Reagent Sales By Major Supplier
  • Summary Table Germany, Molecular Diagnostics Test Volume And Sales Forecast by Major Application
  • Germany, Laboratories Performing DNA Sequencing by Market Segment
  • Germany, Molecular Diagnostics Market Potential Laboratory Universe by Market Segment
  • Germany, Molecular Diagnostics Test Volume Forecast By Major Application
  • Germany, Major Infectious Disease Molecular Diagnostics Test Volume Forecast
  • Germany, Infectious Disease Screening NAT Volume Forecast
  • Germany, Molecular Diagnostics Market Forecast By Major Application
  • Germany, Infectious Disease Screening NAT Reagent Market Forecast by Test
  • Germany, Molecular Diagnostics Market by Major Supplier
  • Germany, HIV/Hepatitis NAT Market Reagent Sales by Major Supplier
  • Summary Table Italy, Molecular Diagnostics Test Volume And Sales Forecast by Major Application
  • Italy, Laboratories Performing DNA Sequencing by Market Segment
  • Italy, Molecular Diagnostics Market Potential Laboratory Universe by Market Segment
  • Italy, Molecular Diagnostics Test Volume Forecast By Major Application
  • Italy, Major Infectious Disease Molecular Diagnostics Test Volume Forecast
  • Italy, Infectious Disease Screening NAT Volume Forecast
  • Italy, Molecular Diagnostics Market Forecast By Major Application
  • Italy, Infectious Disease Screening Nat Reagent Market Forecast by Test
  • Italy, Molecular Diagnostics Market By Major Supplier
  • Italy, HIV/Hepatitis NAT Market By Major Supplier
  • Summary Table Spain, Molecular Diagnostics Test Volume And Sales Forecast by Major Application
  • Spain, Laboratories Performing DNA Sequencing by Market Segment
  • Spain, Molecular Diagnostics Market, Potential Laboratory Universe by Market Segment
  • Spain, Molecular Diagnostics Test Volume Forecast by Major Application
  • Spain, Major Infectious Disease Molecular Diagnostics Test Volume Forecast
  • Spain, Infectious Disease Screening NAT Volume Forecast
  • Spain, Molecular Diagnostics Market Forecast By Major Application
  • Spain, Infectious Disease Screening Nat Reagent Market Forecast by Test
  • Spain, Molecular Diagnostics Market By Major Supplier
  • Spain, HIV/Hepatitis NAT Market Reagent Sales by Major Supplier
  • Summary Table U.K., Molecular Diagnostics Test Volume And Sales Forecast by Major Application
  • U.K., Laboratories Performing Dna Sequencing by Market Segment
  • U.K., Molecular Diagnostics Market Potential Laboratory Universe by Market Segment
  • U.K., Molecular Diagnostics Test Volume Forecast By Major Application
  • U.K., Major Infectious Disease Molecular Diagnostics Test Volume Forecast
  • U.K., Infectious Disease Screening NAT Volume Forecast
  • U.K., Molecular Diagnostics Market Forecast By Major Application
  • U.K., Infectious Disease Screening NAT Reagent Market Forecast by Test
  • U.K., Molecular Diagnostics Market by Major Supplier
Back to Top